Microbot Medical Inc [NASDAQ: MBOT] surged by $0.35 during the normal trading session on while it closed the day at $2.43.
Microbot Medical Inc stock has also loss -1.22% of its value over the past 7 days. However, MBOT stock has inclined by 27.23% in the 3 months of the year. Over the past six months meanwhile, it has gained 144.07% and gained 116.96% year-on date.
The market cap for MBOT stock reached $84.43 million, with 34.74 million shares outstanding and 31.69 million shares in the current float. Compared to the average trading volume of 3.05M shares, MBOT reached a trading volume of 3445672 in the most recent trading day, which is why market watchdogs consider the stock to be active.
Here’s what leading stock market gurus have to say about Microbot Medical Inc [MBOT]:
Based on careful and fact-backed analyses by Wall Street experts, the current consensus on the target price for MBOT shares is $9.00 per share. Analysis on target price and performance of stocks is usually carefully studied by market experts, and the current Wall Street consensus on MBOT stock is a recommendation set at 1.00. This rating represents a strong Buy recommendation, on the scale from 1 to 5, where 5 would mean strong sell, 4 represents Sell, 3 is Hold, and 2 indicates Buy.
H.C. Wainwright have made an estimate for Microbot Medical Inc shares, keeping their opinion on the stock as Buy, with their previous recommendation back on January 13, 2020. While these analysts kept the previous recommendation, H.C. Wainwright raised their target price from $10 to $12. The new note on the price target was released on December 24, 2019, representing the official price target for Microbot Medical Inc stock. Previously, the target price had yet another raise to $1.75, while Ladenburg Thalmann analysts kept a Buy rating on MBOT stock.
The Average True Range (ATR) for Microbot Medical Inc is set at 0.27 The Price to Book ratio for the last quarter was 13.35, with the Price to Cash per share for the same quarter was set at 0.16.
MBOT stock trade performance evaluation
Microbot Medical Inc [MBOT] fell into the red zone at the end of the last week, falling into a negative trend and dropping by -1.22. With this latest performance, MBOT shares gained by 52.83% in over the last four-week period, additionally plugging by 144.07% over the last 6 months – not to mention a rise of 173.80% in the past year of trading.
Overbought and oversold stocks can be easily traced with the Relative Strength Index (RSI), where an RSI result of over 70 would be overbought, and any rate below 30 would indicate oversold conditions. An RSI rate of 50 would represent a neutral market momentum. The current RSI for MBOT stock in for the last two-week period is set at 63.74, with the RSI for the last a single of trading hit 65.22, and the three-weeks RSI is set at 61.86 for Microbot Medical Inc [MBOT]. The present Moving Average for the last 50 days of trading for this stock 1.72, while it was recorded at 2.26 for the last single week of trading, and 1.30 for the last 200 days.
Microbot Medical Inc [MBOT]: An insightful look at the core fundamentals
Microbot Medical Inc’s liquidity data is similarly interesting compelling, with a Quick Ratio of 2.37 and a Current Ratio set at 2.37.
Microbot Medical Inc [MBOT]: Institutional Ownership
There are presently around $7.47%, or 7.60%% of MBOT stock, in the hands of institutional investors. The top three institutional holders of MBOT stocks are: VANGUARD GROUP INC with ownership of 0.46 million shares, which is approximately 3.0953%. BLACKROCK INC., holding 0.14 million shares of the stock with an approximate value of $$0.14 million in MBOT stocks shares; and BLACKROCK INC., currently with $$0.12 million in MBOT stock with ownership which is approximately 0.8078%.
